Balancing risks and benefits in pain medicine: wither Vioxx.
Gallagher
Rollin M
RM
D003257:Consumer Product Safety / Q000331:legislation & jurisprudence / Q000592:standards; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D004335:Drug and Narcotic Control / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000517:prevention & control; D011300:Preoperative Care / Q000639:trends; D018570:Risk Assessment / Q000191:economics / Q000592:standards; D013450:Sulfones / Q000009:adverse effects* / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib